New vaccine aims to shield kids from 24 pneumococcal strains
NCT ID NCT06800261
First seen Jan 31, 2026 · Last updated May 25, 2026 · Updated 13 times
Summary
This study tests a new vaccine (PCV24) that protects against 24 types of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. It involves 180 healthy children aged 2 to 23 months. The goal is to see if the vaccine is safe and triggers a strong immune response, compared to an existing vaccine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shandong Provincial Center for Disease Control and Prevention
NOT_YET_RECRUITINGJinan, Shandong, 250014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanxian Center for Disease Control and Prevention
RECRUITINGShancheng, Shandong, 250014, China
Contact
Conditions
Explore the condition pages connected to this study.